Literature DB >> 17362663

COX-2 inhibitors and hypertension.

Alan B Weder1.   

Abstract

Entities:  

Year:  2007        PMID： 17362663     DOI： 10.1007/s11906-007-0001-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   4.592


× No keyword cloud information.
  6 in total

1.  Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Authors:  Tai-Juan Aw; Steven Joseph Haas; Danny Liew; Henry Krum
Journal:  Arch Intern Med       Date:  2005-02-14

2.  Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

Authors:  M Kömhoff; H J Grone; T Klein; H W Seyberth; R M Nüsing
Journal:  Am J Physiol       Date:  1997-04

Review 3.  Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials.

Authors:  Jingjing Zhang; Eric L Ding; Yiqing Song
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

Review 4.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

Authors:  Patricia McGettigan; David Henry
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

5.  Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.

Authors:  Patricia M Kearney; Colin Baigent; Jon Godwin; Heather Halls; Jonathan R Emberson; Carlo Patrono
Journal:  BMJ       Date:  2006-06-03

Review 6.  Nephrotoxic potential of selective cyclooxygenase-2 inhibitors.

Authors:  Gurbir K Sandhu; Catherine A Heyneman
Journal:  Ann Pharmacother       Date:  2004-02-24       Impact factor: 3.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.